Lupin Pharmaceuticals Just Recalled Two Birth Control Pills - Did It Affect The Stock?


Despite the news, Lupin’s share price rose 4% on earnings results and has increased 47% in 2023

Read more at : forbes

Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.